Role of MicroRNAs in Progression and Recurrence of Early-Stage Lung Adenocarcinoma
Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2015, Vol 2, Issue 1
Abstract
Lung cancer is the leading cause of cancer-related death worldwide, and the majority of cases (77%) are not diagnosed until the disease has spread to regional lymph nodes or distant sites. Even among Non-Small Cell Lung Cancer (NSCLC) adenocarcinoma patients who have been diagnosed early and where there has been no spread to lymph nodes, recurrence after surgical intervention is high. Improved understanding of the molecular alterations involved in aggressivity and recurrence of these tumors may provide better biomarkers for the identification of patients who would benefit from adjuvant chemotherapy. By comparing the expression of microRNAs in advanced Stage II/III tumors with those expressed in earlier Stage I tumors, we aimed to identify differentially expressed molecular biomarkers that could underly progression and recurrence of Stage I tumors. This pilot study utilized TaqMan qPCR assays to assess the expression of microRNAs in tumor tissue, matched normal tissue and plasma samples from Stage I and Stage II/III lung adenocarcinoma patients. Seven microRNAs were identified from plasma that could distinguish between patients with Stage I and Stage II/III adenocarcinoma. The up-regulation of miR-29a in plasma of patients with later-stage adenocarcinoma would result in enhanced expression of several molecules involved in integrin signaling, migration and proliferation. Analysis of differential expression of microRNAs in later-stage compared to early-stage lung adenocarcinoma implicates focal adhesion and ECM-receptor pathways in progression and recurrence. Plasma miR-29a is a promising biomarker that can be assessed non-invasively and whose clinical utility should be pursued.
Authors and Affiliations
Susan E. Douglas
Keywords
Related Articles
- EP ID EP550067
- DOI 10.17140/PRRMOJ-2-108
- Views 130
- Downloads 0
Diaphragm Ultrasonography as a Tool To Assess the Respiratory Issues of a Patient With Amyotrophic Lateral Sclerosis (ALS)
A 73-year-old woman with Amyotrophic Lateral Sclerosis (ALS) presented at a universityaffiliated community hospital with increasing shortness of breath. She was diagnosed with ALS 2 years prior to this event, and she had...
Taste Sensitivity and Nutrition in COPD Rehabilitation
Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease of the lungs characterized by persistent airflow obstruction resulting from inflammation and remodeling of the airways, and may include development of emp...
Elevated Jugular Venous Pressure with Y-Dip on Inspection
An 80-year-old man was transferred to our hospital (day 1) from a local hospital because of persistent dyspnea on exertion for two weeks. He had aortic valve replacement with a mechanical valve for aortic valve stenosis...
Paraneoplastic Syndrome: What should Pulmonologists know?
Pulmonologists often encounter patients with oncologic emergencies (Figure 1) such as metabolic syndrome (tumor lysis syndrome),1 hypercalcemia, syndrome of inappropriate secretion of antidiuretic hormone (SIADH), hemato...
Cultural Differences in Illness Perception and Adherence to Treatment of Cystic Fibrosis Patients
Background: Patients with Cystic Fibrosis (CF) have a complex treatment regimen which poses emotional, social and economic burden. Adherence to treatment may be influenced by the patient’s own beliefs about the disease,...